← Back to patent-cliff list
AP-30663
Tier C — Watch / tradeAP-30663
Acesion Pharma
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：KCNN1
Indications (approved)：Atrial fibrillation
Regional status
US
-
EU
Phase II
2019-09-09
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of AP-30663?
Approved indications include: Atrial fibrillation.
When does the AP-30663 patent expire?
No public expiry year is available for AP-30663 yet; this page updates once verified.
How do I get a quote for AP-30663 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-07